Oncomed Pharma
(OMED)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,525 | -37,833 | -22,608 | -103,102 | -80,764 |
| Depreciation Amortization | 1,286 | 861 | 428 | 1,764 | 1,328 |
| Accounts receivable | 2,167 | 525 | 863 | 68,184 | 68,451 |
| Accounts payable and accrued liabilities | -4,111 | -2,785 | -980 | -1,770 | -1,224 |
| Other Working Capital | -32,660 | -24,443 | -9,921 | 53,271 | 56,574 |
| Other Operating Activity | 9,222 | 7,585 | 3,240 | -55,283 | -58,452 |
| Operating Cash Flow | $-72,621 | $-56,090 | $-28,978 | $-36,936 | $-14,087 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 49,825 | 49,803 | 29,887 | -28,545 | -58,500 |
| PPE Investments | -484 | -464 | -400 | -1,158 | -858 |
| Investing Cash Flow | $49,341 | $49,339 | $29,487 | $-29,703 | $-59,358 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,204 | 1,738 | 1,733 | 65,148 | 65,085 |
| Financing Cash Flow | $2,204 | $1,738 | $1,733 | $65,148 | $65,085 |
| Beginning Cash Position | 36,953 | 36,953 | 36,953 | 38,444 | 38,444 |
| End Cash Position | 15,877 | 31,940 | 39,195 | 36,953 | 30,084 |
| Net Cash Flow | $-21,076 | $-5,013 | $2,242 | $-1,491 | $-8,360 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,621 | -56,090 | -28,978 | -36,936 | -14,087 |
| Capital Expenditure | -484 | -464 | -400 | -1,158 | -858 |
| Free Cash Flow | -73,105 | -56,554 | -29,378 | -38,094 | -14,945 |